Gabapentin add-on for drug-resistant partial epilepsy

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Al Bachari, Sarah ^a   Pulman, Jennifer ^b   Hutton, Jane L ^c   Marson, Anthony G ^b  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; LAMOTRIGINE; PLACEBO; VIGABATRIN; 4 AMINOBUTYRIC ACID; AMINE; ANTICONVULSIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ABNORMAL SENSATION; ADD ON THERAPY; AMNESIA; ANOREXIA; ATAXIA; DEPRESSION; DIARRHEA; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG RESISTANT EPILEPSY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; EPILEPTIC STATE; FATIGUE; FOCAL EPILEPSY; HEADACHE; HUMAN; MENTAL DISEASE; MONONUCLEOSIS; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RESPIRATORY TRACT INFECTION; REVIEW; SEIZURE; SOMNOLENCE; SYSTEMATIC REVIEW; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; VERTIGO; WEAKNESS; ADULT; CHILD; DRUG COMBINATION; DRUG RESISTANCE; META ANALYSIS; METHODOLOGY; TREATMENT FAILURE; EPILEPSIES, PARTIAL; PROCEDURES;

ADULT; AMINES; ANTICONVULSANTS; CHILD; CYCLOHEXANECARBOXYLIC ACIDS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; TREATMENT FAILURE;

EID: 84891653437     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001415.pub2     Document Type: Review

References (25)

1. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 1994;35(4):795-801.
2. Appleton R, Fichtner K, LaMoreaux L, Alexander J, Halsall G, Murray G, et al. and the Gabapentin Paediatric Study Group. Gabapentin as add-on therapy in children with refractory partial seizures: a 12 week, multicentre, double blind placebo controlled study. Epilepsia 1999;40(8):1147-54.
3. Fisher RS, Sachdeo RC, Pellock J, Penovich PE, Mahnus L, Bernstein P. Rapid Initiation of gabapentin: a randomised control trial. Neurology 2001;56:743-8.
4. Leach JP, Girvan J, Paul A, Brodie MJ. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 1997;62(4):372-6.
5. Lindberger M, Alenius M, Frisen L, Johannessen SI, Larsson S, Malmgren K, et al. on behalf of the GREAT Study Investigators Group. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomised, double-blind, dose titration study. Epilepsia 2000;41(10):1289-95.
6. Sethi A, Chandra D, Puir V, Mallika V. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. Neurology India 2002;50(3):359-63.
7. Sivenius J, Kalviainen R, Ylinen A, Riekkinen P. Double blind study of gabapentin in the treatment of partial seizures. Epilepsia 1991;32(4):539-42.
8. Tomovic M, Ilic T, Mihajlovic M, Jovicic A. Gabapentin as adjuvant therapy in the treatment of refractory partial epilepsy. Vojnosanitetski Pregled 1999;56(2):151-6.
9. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990;335(8698):1114-7.
10. The US Gabapentin Study Group No 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993;43(11):2292-8.
11. Yamauchi T, Kaneko S, Vagi K, Sase S. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study. Psychiatry and Clinical Neurosciences 2006;60(4):507-15.
12. Crawford P, Ghadiali E, Lane R, Blumhardt L, Chadwick DW. Gabapentin as an antiepileptic drug in man. Journal of Neurology, Neurosurgery, and Psychiatry 1987;50(6):682-6.
13. Kwan SY, Yiu CH, Su MS. A double blind study of gabapentin in partial seizures. Epilepsia 2000;41(Suppl):69.
14. Shapiro DY, Nordli D, Glauser TA, Knapp LE, Greiner M, Purcell TJ, et al. Gabapentin as add-on therapy for refractory partial seizures in children 1-36 months of age: a novel, short-term, placebo-controlled trial. Epilepsia 2000;41(Suppl 7):106.
15. British National Formulary. http://www.bnf.org/bnf/org_450080.htm.
16. Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the national general practice study of epilepsy. Lancet 1995;346:140-4.
17. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
18. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
19. Kirkham J, Dwan K, Altman D, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365.
20. McClean MJ. Gabapentin. Epilepsia 1995;36 Suppl(2):72-86.
21. McCullagh P, Nelder JA. Generalized Linear Models. 2nd Edition. London: Chapman and Hall, 1989.
22. Reynolds EH, Shorvon SD, Galbraith AW. Phenytoin for epilepsy: a long term prospective study, assisted by serum level monitoring in previously untreated patients. Epilepsia 1981;22:475.
23. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996;313:1169-74.
24. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
25. Marson AG, Kadir ZZ, Hutton JL, Chadwick DW. Gabapentin add-on for drug-resistant partial epilepsy. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD001415]